These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15506656)

  • 1. Construction and immunogenicity of human papillomavirus type 6b L1 recombinant plasmid.
    Liu F; Wang JB; Zuo YG; Liu YH; Ma DL
    Chin Med Sci J; 2004 Sep; 19(3):233-6. PubMed ID: 15506656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of HPV6b L1/EBV LMP2 multiepitope and immunogenicity in mice.
    Zhu S; Xue X; Liu J; Lu L; Zhao P; Wang J; Li W; Zhang L
    Acta Biochim Biophys Sin (Shanghai); 2010 Aug; 42(8):515-21. PubMed ID: 20705592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response to plasmid DNA encoding HPV16-L1 protein.
    Sun X; Si L; Cao Z; Wang Y; Liu T; Guo J
    Chin Med J (Engl); 2000 Mar; 113(3):277-80. PubMed ID: 11775264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective immunity against Chlamydia trachomatis genital infection induced by a vaccine based on the major outer membrane multi-epitope human papillomavirus major capsid protein L1.
    Xu W; Liu J; Gong W; Chen J; Zhu S; Zhang L
    Vaccine; 2011 Mar; 29(15):2672-8. PubMed ID: 21324344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmid encoding papillomavirus Type 16 (HPV16) DNA constructed with codon optimization improved the immunogenicity against HPV infection.
    Cheung YK; Cheng SC; Sin FW; Xie Y
    Vaccine; 2004 Dec; 23(5):629-38. PubMed ID: 15542183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transformation activity and antigenicity of the human papillomavirus type 58 E6E7 fusion gene mutant].
    Wang H; Yu JY; Li L
    Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):491-6. PubMed ID: 24257298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer.
    Baek JO; Seo JW; Kwon O; Park SM; Kim CH; Kim IH
    Enzyme Microb Technol; 2012 Mar; 50(3):173-80. PubMed ID: 22305172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunogenicity study of HPV 6b virus-like particles].
    Liu Y; Liu X; Frazer IH
    Zhonghua Yi Xue Za Zhi; 2002 May; 82(9):587-9. PubMed ID: 12133476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA vaccination of mice with plasmid expressing human papillomavirus 6 major capsid protein L1 elicits type-specific antibodies neutralizing pseudovirions constructed in vitro.
    Matsumoto K; Kawana K; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
    J Med Virol; 2000 Feb; 60(2):200-4. PubMed ID: 10596021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preliminary study of HPV16 L1/E6-E7 chimeric recombinant DNA vaccine plasmid construction and expression in CHO cell].
    Zheng J; Zhang FP; Si LS; Dong XP; Wang YL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Mar; 17(1):66-9. PubMed ID: 12870023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells.
    Mossadegh N; Gissmann L; Müller M; Zentgraf H; Alonso A; Tomakidi P
    Virology; 2004 Aug; 326(1):57-66. PubMed ID: 15262495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro expression of Lgeionella pneumophila pilE gene and its immunogenicity].
    Yang ZW; Chen JP; Wang T; Tian Y; Liu DS
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):141-5. PubMed ID: 17355920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The construction and immune response of fusion DNA vaccine CRT180/HPV6E7].
    Zhao KJ; Cheng H; Xu Y; Zhu KJ; Chen ML; Zhang X; Song T; Wang Q; Chen DF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 38(4):573-7. PubMed ID: 17718414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction and immunogenicity evaluation of chimerical DNA vaccine of human papillomavirus type 11].
    Huang ZH; Li LH; Guo ZJ; Liu ZH; Ren JD; Song MX; Zhou XK; Wang F; Bi ZG
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Jun; 23(3):182-4. PubMed ID: 20104772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombined DNA vaccines encoding calreticulin linked to HPV6bE7 enhance immune response and inhibit angiogenic activity in B16 melanoma mouse model expressing HPV 6bE7 antigen.
    Zhao KJ; Cheng H; Zhu KJ; Xu Y; Chen ML; Zhang X; Song T; Ye J; Wang Q; Chen DF
    Arch Dermatol Res; 2006 Jul; 298(2):64-72. PubMed ID: 16710741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced immunogenicity of human papillomavirus 16 L1 genetic vaccines fused to an ER-targeting secretory signal peptide and RANTES.
    Kim SJ; Lee C; Lee SY; Kim I; Park JS; Sasagawa T; Ko JJ; Park SE; Oh YK
    Gene Ther; 2003 Aug; 10(15):1268-73. PubMed ID: 12858192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Construction of codon-optimized HPV16 capsid genes in the eukaryotic co-expression vector and transfection of cells].
    Liu LH; Xu L; Li YJ; Zhang FC; Ma ZH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jul; 24(7):663-7. PubMed ID: 18616906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunogenicity of mutant and wild HPV16 DNA vaccines].
    Zuo YG; Wang JB; Jin HZ; Yue-hua L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Oct; 26(5):554-7. PubMed ID: 15562771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DNA vaccine constructed with human papillomavirus type 16 (HPV16) E7 and E6 genes induced specific immune responses.
    Yan Q; Cheung YK; Cheng SC; Wang XH; Shi M; Hu MH; Yong X
    Gynecol Oncol; 2007 Jan; 104(1):199-206. PubMed ID: 17049969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prokaryotic expression and identification of human papillomavirus type 16 E5 protein].
    Shi QF; Wei XL; Li H; Wang BN; Zhang WD; Jiang ZH; Cao K; Li MY
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):31-5. PubMed ID: 16495171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.